BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35315281)

  • 1. Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany.
    Wilke T; Weisser B; Predel HG; Schmieder RE; Wassmann S; Gillessen A; Blettenberg J; Maywald U; Randerath O; Müller S; Böhm M
    J Comp Eff Res; 2022 Apr; 11(6):411-422. PubMed ID: 35315281
    [No Abstract]   [Full Text] [Related]  

  • 2. A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination.
    Masi S; Kobalava Z; Veronesi C; Giacomini E; Degli Esposti L; Tsioufis K
    Adv Ther; 2024 Jan; 41(1):182-197. PubMed ID: 37864626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    Snyman JR; Bortolotto LA; Degli Esposti L; Jayagopal PB; Konradi AO; Perrone V; Borghi C
    J Hypertens; 2024 Jan; 42(1):136-142. PubMed ID: 37728093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
    Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O; Andrews LM; Wang L; Xie L
    J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study.
    Wilke T; Weisser B; Predel HG; Schmieder R; Wassmann S; Gillessen A; Blettenberg J; Maywald U; Randerath O; Mueller S; Böhm M
    Integr Blood Press Control; 2022; 15():11-21. PubMed ID: 35250308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
    Sicras Mainar A; Galera Llorca J; Muñoz Ortí G; Navarro Artieda R
    Med Clin (Barc); 2011 Feb; 136(5):183-91. PubMed ID: 21106209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom.
    Danese MD; Gleeson M; Griffiths RI; Catterick D; Kutikova L
    J Med Econ; 2017 Sep; 20(9):931-937. PubMed ID: 28635339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy.
    Yang W; Kahler KH; Fellers T; Orloff J; Chang J; Bensimon AG; Wu EQ; Fan CP; Yu AP
    J Med Econ; 2011; 14(3):267-78. PubMed ID: 21446895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
    Tykarski A; Widecka K; Narkiewicz K; Wożakowska-Kapłon B; Gaciong Z; Grajek S; Grodzicki T; Januszewicz A; Wolf J; Prejbisz A; Kostka-Jeziorny K; Filipiak KJ
    Kardiol Pol; 2017; 75(12):1357-1367. PubMed ID: 29251761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world comparison of hospitalization costs for heart failure in type 2 diabetes mellitus patients with established cardiovascular disease treated with canagliflozin versus other antihyperglycemic agents.
    Chen YW; Voelker J; Tunceli O; Pericone CD; Bookhart B; Durkin M
    J Med Econ; 2020 Apr; 23(4):401-406. PubMed ID: 31801393
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan.
    Wang X; Chen H; E E; Wu J; Serna O; Paranjpe R; Abughosh S
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):829-836. PubMed ID: 32703040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in blood pressure control and the potential role of single-pill combination therapies.
    Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM
    Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.
    Chapman RH; Yeaw J; Roberts CS
    BMC Cardiovasc Disord; 2010 Jun; 10():29. PubMed ID: 20565779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
    Sung J; Ahn KT; Cho BR; Lee SY; Kim BJ; Kim DK; Park JI; Lee WS
    Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of single-pill combination of indapamide and amlodipine in the treatment of arterial hypertension in the Polish setting.
    Kawalec P; Holko P; Stawowczyk E; Borowiec Ł; Filipiak KJ
    Kardiol Pol; 2015; 73(9):768-80. PubMed ID: 25987296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Treatment by Initial Antihypertensive Mono and Combination Therapies.
    Rea F; Savaré L; Franchi M; Corrao G; Mancia G
    Am J Hypertens; 2021 Oct; 34(10):1083-1091. PubMed ID: 34037713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA; Hilleman DE
    Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive Prescribing Pattern in Older Adults: Implications of Age and the Use of Dual Single-Pill Combinations.
    Al Khaja KAJ; James H; Veeramuthu S; Tayem YI; Sridharan K; Sequeira RP
    High Blood Press Cardiovasc Prev; 2019 Dec; 26(6):535-544. PubMed ID: 31797221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.